Related Experiment Videos
Cytotoxin and enterotoxin production by Clostridium difficile
Abstract:
30 strains of Cl. difficile isolated from faeces of patients with pseudomembranous colitis (PMC), antibiotic associated diarrhoea (AAC) and other intestinal disorders and from faeces of asymptomatic carriers were studied for production of toxins. Tissue culture assay was used for the detection of cytotoxin (toxin B) and ileal loop test for enterotoxin (toxin A). All Cl. difficile isolates from patients with PMC and AAC were found to produce cytotoxin, whereas enterotoxin was demonstrated only in approximately 70% of strains.
Insights
Clostridium difficile toxin production was studied in 30 strains. All strains from patients with pseudomembranous colitis and antibiotic-associated diarrhea produced cytotoxin, but only 70% produced enterotoxin.
Area of Science:
- Microbiology
- Gastroenterology
- Toxicology
Background:
- Clostridium difficile is a significant cause of intestinal disorders.
- Toxin production by Clostridium difficile strains varies and influences disease severity.
Purpose of the Study:
- To investigate the toxin production profiles of Clostridium difficile isolates from various patient groups and asymptomatic carriers.
- To correlate toxin production with specific intestinal conditions.
Main Methods:
- Isolation and culture of 30 Clostridium difficile strains from fecal samples.
- Detection of cytotoxin (toxin B) using tissue culture assay.
- Detection of enterotoxin (toxin A) using the ileal loop test.
Main Results:
- All Clostridium difficile isolates from patients with pseudomembranous colitis (PMC) and antibiotic-associated diarrhea (AAC) produced cytotoxin.
- Enterotoxin (toxin A) was detected in approximately 70% of strains isolated from patients with PMC and AAC.
- Toxin production varied among isolates from asymptomatic carriers.
Conclusions:
- Cytotoxin (toxin B) production is a common characteristic of Clostridium difficile strains causing PMC and AAC.
- Enterotoxin (toxin A) is not universally produced by pathogenic Clostridium difficile strains.
- Further research is needed to understand the role of toxin variability in disease pathogenesis.